Economic evaluations of the primary prevention programs for viral hepatitis-related liver disease and liver cancer: a systematic literature review
Primary prevention strategies for viral hepatitis-related liver disease are generally cost-effective, particularly in high-risk populations. Universal screening and early treatment were associated with improved health outcomes, including reductions in hepatocellular carcinoma, cirrhosis, and liver-related mortality. However, significant variations in methodological approaches limit direct comparability across studies and across countries.
Authors
- J. Richard George
- Ann Carrigan (ORCID: https://orcid.org/0000-0002-2525-9241)
- Shenghan Cai (ORCID: https://orcid.org/0000-0002-4277-3365)
- Putu Novi Arfirsta Dharmayani (ORCID: https://orcid.org/0000-0001-8227-1127)
- Stephen Goodall (ORCID: https://orcid.org/0000-0001-6611-6565)
- Shalini Wijekulasuriya (ORCID: https://orcid.org/0000-0002-5269-955X)
- Yvonne Zurynski (ORCID: https://orcid.org/0000-0001-7744-8717)
- Milena Lewandowska
- Rose Boutros
- Amany Zekry
Institutions
- University of Technology Sydney (AU)
- The University of Sydney (AU)
- Sutherland Hospital (AU)
- Westmead Hospital (AU)
- St George Hospital (AU)
- Sydney Local Health District (AU)
- Westmead Institute for Medical Research (AU)
- South Western Sydney Local Health District (AU)
- Macquarie University (AU)
Publication Details
- Journal
- Cost Effectiveness and Resource Allocation
- Published
- 2026-02-19
- DOI
- https://doi.org/10.1186/s12962-026-00727-y
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00